When the patent for a specific drug expires, there is a great effort by the pharmaceutical industries in an attempt to obtain a differentiated product that is effective, increases patient compliance with treatment and can be really competitive in the market. Therefore, the development of innovative formulations is an increasingly evident need in the pharmaceutical industry.

 

• DEINFAR has adequate facilities and experience to work with the following technologies:

• Solid pharmaceutical forms of conventional and controlled release.

• Multiparticulate pharmaceutical forms: pellets obtained by the extrusion-spheronization process, with subsequent drying in a fluidized bed.

• Complexing technologies with cyclodextrins.